Dyslipidemias: Clinical Trials

2 trials for Dyslipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Enrolling by invitation 2
Phase 11Enrolling by invitation 1
Phase 31Enrolling by invitation 1

Follow Dyslipidemias: new trials by email Literature Review of Dyslipidemias trials Research Report on Dyslipidemias

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Atorvastatin 10mg, Modification of dietary fat composition - Epilepsy, Dyslipidemia
Phase 1 / Phase 2Enrolling by invitationJohns Hopkins University222024-10-042026-10-19
Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine
Berberine, Placebo - Hyperlipidemia
Phase 2 / Phase 3Enrolling by invitationThe University of Hong Kong1002024-08-012025-01-20

Narrower conditions

Epilepsy (1)  ·  Hyperlipidemias (1)

Broader conditions

Lipid Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)

Interventions

Atorvastatin (1)  ·  Berberine (1)

Sponsors

Johns Hopkins University (1)  ·  The University of Hong Kong (1)

Countries

Hong Kong (1)  ·  United States (1)

Top investigators

Jie Zhao, Dr (1)  ·  Tanya J McDonald, MD, PhD (1)